Local Therapy with Continued EGFR Tyrosine Kinase Inhibitor Therapy as a Treatment Strategy in EGFR-Mutant Advanced Lung Cancers That Have Developed Acquired Resistance to EGFR Tyrosine Kinase Inhibitors

Helena A. Yu; Camelia S. Sima; James Huang; Stephen B. Solomon; Andreas Rimner; Paul K. Paik; M. Catherine Pietanza; Christopher G. Azzoli; Naiyer A. Rizvi; Lee M. Krug; Vincent A. Miller; Mark G. Kris; Gregory J. Riely

doi:10.1097/jto.0b013e31827e1f83

Local Therapy with Continued EGFR Tyrosine Kinase Inhibitor Therapy as a Treatment Strategy in EGFR-Mutant Advanced Lung Cancers That Have Developed Acquired Resistance to EGFR Tyrosine Kinase Inhibitors

著者: Helena A. Yu, Camelia S. Sima, James Huang, Stephen B. Solomon, Andreas Rimner, Paul K. Paik, M. Catherine Pietanza, Christopher G. Azzoli, Naiyer A. Rizvi, Lee M. Krug, Vincent A. Miller, Mark G. Kris, Gregory J. Riely - Journal of Thoracic Oncology 2013 被引用: 342

Local Therapy with Continued EGFR Tyrosine Kinase Inhibitor Therapy as a Treatment Strategy in EGFR-Mutant Advanced Lung Cancers That Have Developed Acquired Resistance to EGFR Tyrosine Kinase Inhibitors | Litlas